Guatemala rejects pharmaceutical industry's plea for price increases

The Guatemalan government refused to give in to demands from the pharmaceutical industry for a new contract between the two sides that would include higher prices. Both parties opted instead to continue the present agreement until next year.

Tuesday, May 20, 2008

In February agreement was reached on a 6 percent price increase through August, but the industry wants to raise it to 15 percent.
Luis Gabriel López, the deputy health minister, said: "The economic situation is bad enough as it is without adding to people's financial burden."

More on this topic

Medicines: Price Control Rejection

September 2020

The business sector in Guatemala rejects the measure of the Ministry of Economy, which establishes maximum sales prices to the consumer for certain pharmaceutical products, while the state of disaster decreed by covid-19 lasts.

On September 1, a Government Agreement was published in the Diario de Centroamérica, in which the government decided to control the prices of several medicines, arguing that the health of the inhabitants of the Nation is a public good and that institutions are required to ensure its conservation and restoration.

Medicines: Maximum Prices Are Fixed

September 2020

The Ministry of Economy of Guatemala issued an agreement establishing maximum sales prices to consumers for certain pharmaceutical products, while the state of calamity decreed by covid-19 lasts.

Arguing that the health of the nation's inhabitants is a public good and that institutions are required to ensure its conservation and restoration, the government will regulate the prices of several medicines.

High Price of Medicines in Costa Rica

December 2012

A study by the Universidad de Costa Rica notes that one company controls the distribution of 80% of drugs sold, with price differences of up to 1,000%.

An article in reports that there is "little or no competition in the private sector of medicine, product of an industry that is "highly concentrated", causing Costa Rica to have higher drug prices compared to other Central American countries."

Drug Prices Regulation Project Questioned

November 2012

Although the bill that regulates the drug prices in Costa Rica, is based on good 'intentions', imposing maximum prices and profits for the pharmaceutical industry is not right.

So said Deputy Economy Minister Marvin Rodriguez, regarding bill 17. 738, on drug price regulation, which imposes limits on drug prices.

 close (x)

Receive more news about Business and Investment

Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.

Type in your e-mail address:

* Al suscribirse, estará aceptando los terminos y condiciones

Girasol Pharma S.A.

Organization that operates in Panama, Panama, Costa Rica, Honduras, El Salvador, Nicaragua and Guatemala.
Phone: (507) 65456121

Girasol Pharma is a school of clinical pharmacist contracted for Santos de Rey Medical Group, where it participates in the activities of direct attention to the patient in the management of pharmacological therapy, geriatrics and anticoagulation clinics.

Company Profile

Stock Indexes

(Apr 6)
Dow Jones
S&P 500


(Jan 27)
Brent Crude Oil
Coffee "C"